Posters

Long-term follow-up after implantation of the iris-fixated Artiflex PIOL

Poster Details

First Author: I.Koh SOUTH KOREA

Co Author(s):    S. Nam   S. Park   H. Yang   I. Kim           

Abstract Details

Purpose:

To evaluate the long-term (> 5 years) safety and efficacy of the Artiflex phakic intraocular lens (PIOL; Ophtec, Groningen, The Netherlands)

Setting:

Single center evaluation ( SU Yonesei Eye Clinic )

Methods:

A retrospective analysis was performed on patients with a minimal follow-up of 5 years after implantation of a phakic Artiflex IOL. The main outcome parameters were refractive stability, UDVA, CDVA and endothelial cell count (ECC).

Results:

Data from 87 eyes from 45 patients with a minimal follow-up of 5 years (average of 5.8 years) was analyzed. The Artiflex provided good refractive stability over time. The mean refraction at 1M was -0.09 �Â�± 0.35 D, at the last follow-up the refraction was -0.26 �Â�± 0.33 D. The mean UCVA at the last follow-up was -0.03 �Â�± 0.10 logMAR, the mean CDVA was -0.07 �Â�± 0.08 logMAR. The mean ECC changed from 2961 cells / mm2 pre-operative to 2743 cells/ mm2 at the last follow-up, the average cell loss was 7.4%.

Conclusions:

The long-term follow-up of the Artiflex PIOL for the patients with adequate anterior chamber depth showed a high refractive stability over time with excellent safety and efficacy scores and acceptable levels of ECC loss.

Financial Disclosure:

NONE